Similar articles

• [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].

  Grazi S, Romano S, Bonazzi O, Pozzoni L, Cavoretto D, Gardumi M, Sardella F. Grazi S, et al. Cardiol Prat. 1974 Jul-Sep;25(3):213-8. Cardiol Prat. 1974. PMID: 4434374 Italian. No abstract available.
• [A study of the mechanism of the action of Bunaphtine recording the myocardial monophasic action potentials in man. Conclusive report (author's transl)].

  Bonatti V, Finardi A, Cabasson J, Botti G. Bonatti V, et al. G Ital Cardiol. 1976;6(8):1378-83. G Ital Cardiol. 1976. PMID: 1010248 Italian.
• Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

  Olsson SB, Brorson L, Varnauskas E. Olsson SB, et al. Br Heart J. 1973 Dec;35(12):1255-9. doi: 10.1136/hrt.35.12.1255. Br Heart J. 1973. PMID: 4586372 Free PMC article. Clinical Trial. No abstract available.
• Delayed repolarization as antiarrhythmic action.

  Olsson SB, Edvardsson N. Olsson SB, et al. Eur Heart J. 1988 Feb;9 Suppl B:37-43. doi: 10.1093/eurheartj/9.suppl_b.37. Eur Heart J. 1988. PMID: 3286265 Review. No abstract available.
• Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.

  Carmeliet E. Carmeliet E. Acta Cardiol Suppl. 1980;(25):5-25. Acta Cardiol Suppl. 1980. PMID: 6246694 Review. No abstract available.